<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698917</url>
  </required_header>
  <id_info>
    <org_study_id>15/2015</org_study_id>
    <nct_id>NCT02698917</nct_id>
  </id_info>
  <brief_title>Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation</brief_title>
  <acronym>COMACARE</acronym>
  <official_title>Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation - Targeting High vs. Low Normal Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laerdal Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finska Läkaresällskapet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Orion Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnish Society of Anaesthesiologists</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COMACARE trial is a pilot multicenter randomized trial to assess the feasibility and
      effect on brain injury markers of targeting low or high normal arterial oxygen tension
      (PaO2), arterial carbon dioxide tension (PaCO2) and mean arterial pressure (MAP) in comatose,
      mechanically ventilated patients after out-of-hospital cardiac arrest. Using factorial
      design, participants are randomized at admission to intensive care unit to one of eight
      groups targeting either low or high normal values of PaO2, PaCO2 and MAP for 36 h. In this
      way, investigators will be assessing the feasibility and effect of all three variables at the
      same time.

      The primary outcome is serum concentration of neuron-specific enolase (NSE) at 48 h after
      cardiac arrest. Feasibility outcome is between-group separation in PaO2, PaCO2 and MAP
      levels. Secondary outcomes include continuous monitoring of cerebral oxygenation, EEG and ECG
      for 48 h, the levels of NSE, S100B and cardiac troponin at randomization and 24, 48 and 72 h
      after cardiac arrest and neurological assessment at 6 months after cardiac arrest.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 22, 2016</start_date>
  <completion_date type="Anticipated">June 3, 2018</completion_date>
  <primary_completion_date type="Actual">November 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The physician determining neurological outcome at six months after cardiac arrest is blinded to the study group allocations</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Neuron-specific enolase (NSE) serum concentration</measure>
    <time_frame>48 hour after cardiac arrest</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuron-specific enolase (NSE) serum concentration</measure>
    <time_frame>At randomization and 24 and 72 hour after cardiac arrest</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S100B protein serum concentration</measure>
    <time_frame>At randomization and 24, 48 and 72 hour after cardiac arrest</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac troponin (TnT) serum concentration</measure>
    <time_frame>At randomization and 24, 48 and 72 hour after cardiac arrest</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral oxygenation monitoring using near infrared spectroscopy (NIRS) monitoring</measure>
    <time_frame>For 48 hour after admission to ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous electroencephalography (EEG) monitoring</measure>
    <time_frame>For 48 hour after admission to ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status using cerebral performance category (CPC) classification</measure>
    <time_frame>At 30 days and 6 months after cardiac arrest</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Between-group separation in PaCO2</measure>
    <time_frame>Every 3 hour for 36 hour after admission to ICU</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Between-group separation in PaO2</measure>
    <time_frame>Every 3 hour for 36 hour after admission to ICU</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Between-group separation in MAP</measure>
    <time_frame>Every 1 hour for 36 hour after admission to ICU</time_frame>
  </other_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Out-of-Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low normal PaCO2, low normal PaO2, low normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High normal PaCO2, low normal PaO2, low normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low normal PaCO2, high normal PaO2, low normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High normal PaCO2, high normal PaO2, low normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low normal PaCO2, low normal PaO2, high normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High normal PaCO2, low normal PaO2, high normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 7</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low normal PaCO2, high normal PaO2, high normal MAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High normal PaCO2, high normal PaO2, high normal MAP</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low normal PaCO2</intervention_name>
    <description>4.5-4.7 kPa</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High normal PaCO2</intervention_name>
    <description>5.8-6.0 kPa</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_label>Group 8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low normal PaO2</intervention_name>
    <description>10-15 kPa</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High normal PaO2</intervention_name>
    <description>20-25 kPa</description>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
    <arm_group_label>Group 8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low normal MAP</intervention_name>
    <description>65-75 mmHg</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High normal MAP</intervention_name>
    <description>80-100 mmHg</description>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
    <arm_group_label>Group 8</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Witnessed out-of-hospital cardiac arrest with ventricular fibrillation (VF) or
             ventricular tachycardia (VT) as the initial rhythm

          -  Delay of return of spontaneous circulation (ROSC) 10-45 min from the start of the
             arrest

          -  Confirmed or suspected cardiac origin

          -  Mechanical ventilation

          -  Markedly impaired level of consciousness (no response to verbal commands and Glasgow
             coma scale [GCS] motor score &lt; 5)

          -  Deferred consent possible or likely

          -  Active intensive care initiated, including targeted temperature management (33-36 C)

        Exclusion Criteria:

          -  Probable withdrawal of active ICU care due to terminal illness or poor prognosis
             because of severely reduced functional status before cardiac arrest

          -  Confirmed or suspected intracranial pathology and/or suspicion of raised intracranial
             pressure

          -  Pregnancy

          -  Severe oxygenation problem (PaO2 / FiO2 &lt; 100 mmHg)

          -  Severe COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matti Reinikainen, Associate Professor</last_name>
    <role>Study Director</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Karelia Central Hospital</name>
      <address>
        <city>Joensuu</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Finland Central Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Päijät-Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>March 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Pekka Jakkula</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Out-of-Hospital Cardiac Arrest</keyword>
  <keyword>Resuscitation</keyword>
  <keyword>Hypoxia-Ischemia, Brain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

